MedPath

Impact of ILM Peeling in RRD/ I-Peel

Not Applicable
Conditions
Retinal Detachment
Interventions
Procedure: ILM (inner limiting membrane) peeling
Registration Number
NCT04767555
Lead Sponsor
Berner Augenklinik
Brief Summary

Retinal detachment is associated with a substantial risk of re-detachment in 10-20% and to the formation of secondary epiretinal membranes in up to 15%. Relevant postoperative vision loss is encountered in many instances, primarily in consequence of macular involvement, but also secondarily due to postoperative complications, namely the formation of an epiretinal membrane and proliferative vitreoretinopathy. These mechanical reasons of influence can potentially be prevented by ILM peeling during reattachment surgery. This, however, is not a generally accepted standard of care during primary routine vitrectomy.

Two groups suffering from primary retinal detachment will be compared: the first group will receive standard re-attachment vitrectomy surgery, whereas the second group will receive an identical vitrectomy surgery, but with additional ILM peeling. In this study, the investigators wish to assess the influence of ILM peeling on visual outcomes and postoperative complications over 12 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
250
Inclusion Criteria
  • primary rhegmatogenous retinal detachment
  • of legal age (18 years or older)
  • in case of bilateral retinal detachment, only the first-affected eye will be included
Exclusion Criteria
  • pre-existing functional and morphological changes to the macula, hindering visual recovery (amblyopia, trauma, macular degeneration)
  • advanced retinal detachment with PVR stage C2 or more
  • eyes pre-operated within six months prior to the development of RD
  • state after any vitreoretinal surgery
  • state after complicated cataract surgery, including aphakia and anterior chamber lens implantation
  • patients with increased risk profiles
  • myopia magna (≥7 diopters)
  • advanced diabetic retinopathy
  • any chronic ocular or systemic inflammatory disease
  • any other proliferative systemic disease or condition associated with impaired wound healing

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ILM (inner limiting membrane) peelingILM (inner limiting membrane) peelingILM peeling adding to standard vitreous surgery in patients suffering from retinal detachment
Primary Outcome Measures
NameTimeMethod
Number of patients developing secondary epiretinal membrane formation12 months

Clinically significant secondary epiretinal membrane formation requiring revision surgery

Secondary Outcome Measures
NameTimeMethod
Complication rates12 months

Intra- and postoperative complication rates including PVR

Surgical timesminutes (0-300)

How long does the surgery take

Rate of re-detachments in patients12 months

Revision surgery due to re-detachment independently of secondary epiretinal membrane formation

Best-corrected visual acuity12 months

Change in best-corrected visual acuity

Trial Locations

Locations (1)

Berner Augenklinik

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath